HCA250117C315000
- 4.00
- -0.50-11.11%
HCA Healthcare Newsroom
HCA Healthcare Shares Are Trading Higher. Keybanc Maintained an Overweight Rating on the Stock.
KeyBanc Adjusts HCA Healthcare's Price Target to $370 From $420, Maintains Overweight Rating
KeyBanc Lowers Price Target on HCA Healthcare to $370 From $420, Keeps Overweight Rating
What Is HCA Healthcare, Inc.'s (NYSE:HCA) Share Price Doing?
KeyBanc Maintains HCA Healthcare(HCA.US) With Buy Rating, Cuts Target Price to $370
Press Release: HCA Healthcare, Inc. 4th Quarter 2024 Earnings Conference Call
Express News | HCA Healthcare, Inc. 4TH Quarter 2024 Earnings Conference Call
Truist Financial Maintains HCA Healthcare(HCA.US) With Buy Rating, Announces Target Price $390
HCA Healthcare Analyst Ratings
Express News | HCA Healthcare Inc : Truist Securities Cuts Target Price to $390 From $430
U.S. Healthcare Execs Turn More Bullish for 2025: Deloitte
No S&P 500 Stocks Are Overbought, but These Are the 10 Most Oversold Names
Unusual Options Activity: ON, XOM and Others Attract Market Bets, ON V/OI Ratio Reaches 299.1
EST Jan 2nd Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Jim Cramer's Take on HCA Healthcare (HCA): Bold Predictions for the Future
We Like HCA Healthcare's (NYSE:HCA) Returns And Here's How They're Trending
Looking Into HCA Healthcare's Recent Short Interest
Ondine Biomedical Treats First Patient in Late-stage Trial of Nasal Infection Technology
Why The 24% Return On Capital At HCA Healthcare (NYSE:HCA) Should Have Your Attention
HCA Healthcare, Inc. (HCA): Among the Cheap Healthcare Stocks to Buy Heading Into 2025
Why Is HCA Healthcare, Inc. (HCA) Among Diamond Hill Capital's Top Stock Picks?